Literature DB >> 11698070

Antitussive action of nociceptin in the cat.

D C Bolser1, R L McLeod, D B Tulshian, J A Hey.   

Abstract

Experiments were conducted to determine the influence of the specific ORL1 receptor agonist, nociceptin, on the cough reflex in the cat. Cats were anesthetized and allowed to breathe spontaneously. Cough was elicited by mechanical stimulation of the intrathoracic airway. Intravenous administration of nociceptin (0.001-3.0 mg x kg(-1)) inhibited cough number and the magnitude of abdominal muscle electromyogram (EMG) discharge during cough in a dose-dependent manner. Nociceptin had no effect on the magnitude of the inspiratory muscle EMG during cough. These effects of nociceptin were antagonized by pretreatment with the ORL1 receptor antagonist, 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397, 0.1 mg x kg(-1), i.v.). We conclude that intravenous nociceptin inhibits cough in the cat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698070     DOI: 10.1016/s0014-2999(01)01244-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.

Authors:  Nurulain T Zaveri
Journal:  J Med Chem       Date:  2016-03-14       Impact factor: 7.446

2.  Coordination of cough and swallow: a meta-behavioral response to aspiration.

Authors:  Teresa Pitts; Melanie J Rose; Ashley N Mortensen; Ivan Poliacek; Christine M Sapienza; Bruce G Lindsey; Kendall F Morris; Paul W Davenport; Donald C Bolser
Journal:  Respir Physiol Neurobiol       Date:  2013-08-30       Impact factor: 1.931

3.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 4.  Encoding of the cough reflex.

Authors:  Brendan J Canning
Journal:  Pulm Pharmacol Ther       Date:  2006-12-30       Impact factor: 3.410

Review 5.  The management of cough: a clinical year in review.

Authors:  Lorcan McGarvey
Journal:  Lung       Date:  2009-08-22       Impact factor: 2.584

6.  The efficacy of a NOP1 agonist (SCH486757) in subacute cough.

Authors:  Ashley Woodcock; Robbie L McLeod; Jonathan Sadeh; Jaclyn A Smith
Journal:  Lung       Date:  2010-01       Impact factor: 2.584

7.  Feed-forward and reciprocal inhibition for gain and phase timing control in a computational model of repetitive cough.

Authors:  Teresa Pitts; Kendall F Morris; Lauren S Segers; Ivan Poliacek; Melanie J Rose; Bruce G Lindsey; Paul W Davenport; Dena R Howland; Donald C Bolser
Journal:  J Appl Physiol (1985)       Date:  2016-06-09

8.  Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Authors:  Robbie L McLeod; Deen B Tulshian; Donald C Bolser; Geoffrey B Varty; Marco Baptista; Xiomara Fernandez; Leonard E Parra; Jennifer C Zimmer; Christine H Erickson; Ginny D Ho; Yanlin Jia; Fay W Ng; Walter Korfmacher; Xiaoying Xu; John Veals; April Smith-Torhan; Samuel Wainhaus; Ahmad B Fawzi; Theodore M Austin; Margaret van Heek; John A Hey
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

Review 9.  Central mechanisms II: pharmacology of brainstem pathways.

Authors:  D C Bolser
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Nociceptin inhibits vanilloid TRPV-1-mediated neurosensitization induced by fenoterol in human isolated bronchi.

Authors:  Christophe Faisy; Emmanuel Naline; Céline Rouget; Paul-André Risse; Emmanuel Guerot; Jean-Yves Fagon; Thierry Chinet; Nicolas Roche; Charles Advenier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.